Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Nab-paclitaxel, and Cetuximab in Head and Neck Cancer
NCT01412229Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Feb 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Feb 2012; status: completed.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01412229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412229.